Wolf Haldenstein Adler Freeman & Herz investigates Siga Technologies for potential securities violations after former NYC COVID czar Jay Varma, who was on Siga’s board, admitted to promoting Siga’s monkeypox drug TPOXX despite low public risk. Varma’s comments aimed to maintain investor confidence, but Siga’s stock dropped 15% post-revelation. Siga fired Varma and distanced itself from his comments, asserting TPOXX’s effectiveness.